237 related articles for article (PubMed ID: 24767701)
1. Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.
Onishi H; Kawasaki T; Zakoji H; Yoshida T; Komiyama T; Kuriyama K; Araya M; Saito R; Aoki S; Maehata Y; Tominaga L; Marino K; Watanabe I; Oguri M; Araki T; Enomoto N; Takeda M; Katoh R
BMC Res Notes; 2014 Apr; 7():270. PubMed ID: 24767701
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated postoperative irradiation in localized renal cell cancer: A case report and pertinent literature review.
Zhao XR; Shan GL; Zhang Y; Yu YH
J Cancer Res Ther; 2018; 14(Supplement):S260-S262. PubMed ID: 29578185
[TBL] [Abstract][Full Text] [Related]
3. Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy.
Funayama S; Onishi H; Kuriyama K; Komiyama T; Marino K; Araya M; Saito R; Aoki S; Maehata Y; Nonaka H; Tominaga L; Muramatsu J; Nakagomi H; Kamiyama M; Takeda M
Technol Cancer Res Treat; 2019 Jan; 18():1533033818822329. PubMed ID: 30803362
[TBL] [Abstract][Full Text] [Related]
4. Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery.
Teh BS; Bloch C; Paulino AC; Shen S; Hinckley L; Baskin D; Butler EB; Amato R
Clin Genitourin Cancer; 2007 Jun; 5(5):334-7. PubMed ID: 17645831
[TBL] [Abstract][Full Text] [Related]
5. Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report.
Ishikawa Y; Yamamoto T; Umezawa R; Takahashi N; Takeda K; Suzuki Y; Jingu K
J Med Case Rep; 2022 Oct; 16(1):353. PubMed ID: 36184609
[TBL] [Abstract][Full Text] [Related]
6. Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma.
Ponsky L; Lo SS; Zhang Y; Schluchter M; Liu Y; Patel R; Abouassaly R; Welford S; Gulani V; Haaga JR; Machtay M; Ellis RJ
Radiother Oncol; 2015 Oct; 117(1):183-7. PubMed ID: 26362723
[TBL] [Abstract][Full Text] [Related]
7. Salvage robot-assisted partial nephrectomy for the management of renal cell carcinoma following failed stereotactic radiotherapy.
Gorin MA; Gorbatiy V; Glenn C; Shirodkar SP; Castle SM; Jorda M; Leveillee RJ
JSLS; 2012; 16(1):159-62. PubMed ID: 22906347
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
[TBL] [Abstract][Full Text] [Related]
9. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-PSMA PET/CT to Distinguish Brain Metastasis of Renal Cell Carcinoma From Radiation Necrosis After Stereotactic Radiosurgery.
Filizoglu N; Cetin IA; Kissa TN; Niftaliyeva K; Ones T
Clin Nucl Med; 2021 Nov; 46(11):913-914. PubMed ID: 34284481
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
Svedman C; Karlsson K; Rutkowska E; Sandström P; Blomgren H; Lax I; Wersäll P
Acta Oncol; 2008; 47(8):1578-83. PubMed ID: 18607859
[TBL] [Abstract][Full Text] [Related]
12. 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).
Siva S; Ali M; Correa RJM; Muacevic A; Ponsky L; Ellis RJ; Lo SS; Onishi H; Swaminath A; McLaughlin M; Morgan SC; Cury FL; Teh BS; Mahadevan A; Kaplan ID; Chu W; Grubb W; Hannan R; Staehler M; Warner A; Louie AV
Lancet Oncol; 2022 Dec; 23(12):1508-1516. PubMed ID: 36400098
[TBL] [Abstract][Full Text] [Related]
13. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
Miccio J; Johung K
Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.
Pham D; Thompson A; Kron T; Foroudi F; Kolsky MS; Devereux T; Lim A; Siva S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1061-8. PubMed ID: 25442039
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma.
Wang YJ; Han TT; Xue JX; Chang DS; Li HQ; Li P; Wang JD; Wang YJ; Xia TY
Radiol Med; 2014 Nov; 119(11):878-83. PubMed ID: 24696288
[TBL] [Abstract][Full Text] [Related]
16. Renal radiosurgery: initial clinical experience with histological evaluation.
Ponsky LE; Mahadevan A; Gill IS; Djemil T; Novick AC
Surg Innov; 2007 Dec; 14(4):265-9. PubMed ID: 18178914
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic metastases from renal cell carcinoma treated with stereotactic body radiation therapy.
Bourlon MT; Amini A; Kavanagh BD; Flaig TW
Oncology (Williston Park); 2014 Nov; 28(11):1008-12. PubMed ID: 25560737
[No Abstract] [Full Text] [Related]
18. Stereotactic Body Radiotherapy for a Rare Case of Sinonasal Metastasis Arising from Renal Cell Cancer.
Cuccia F; Pastorello E; Vitale C; Figlia V; Levra NG; Mazzola R; Nicosia L; Ricchetti F; Rigo M; Ruggieri R; Alongi F
In Vivo; 2023; 37(1):490-492. PubMed ID: 36593020
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy for inoperable patients with renal carcinoma.
Kotzki L; Udrescu C; Lapierre A; Badet L; Rouviere O; Paparel P; Chapet O
Fr J Urol; 2024 Mar; 34(2):102575. PubMed ID: 38364353
[TBL] [Abstract][Full Text] [Related]
20. Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer.
Hannan R; McLaughlin MF; Pop LM; Pedrosa I; Kapur P; Garant A; Ahn C; Christie A; Zhu J; Wang T; Robles L; Durakoglugil D; Woldu S; Margulis V; Gahan J; Brugarolas J; Timmerman R; Cadeddu J
Eur Urol; 2023 Sep; 84(3):275-286. PubMed ID: 36898872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
